Catheter Related - Gram Positive Bloodstream Infections
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
-Evaluate the clinical efficacy and safety of Daptomycin given for treatment of
catheter-related bloodstream infections (CRBSI) due to gram positive bacteremia in the
context of standard of care antimicrobial therapy consisting mainly of Vancomycin with or
without initial treatment with beta lactam antibiotics.